Cargando…

Lymphopenic community acquired pneumonia as signature of severe COVID-19 infection

Detalles Bibliográficos
Autores principales:	Bermejo-Martin, Jesús F, Almansa, Raquel, Menéndez, Rosario, Mendez, Raúl, Kelvin, David J, Torres, Antoni
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The British Infection Association. Published by Elsevier Ltd. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7133663/ https://www.ncbi.nlm.nih.gov/pubmed/32145214 http://dx.doi.org/10.1016/j.jinf.2020.02.029

Ejemplares similares

Lymphopenic Community Acquired Pneumonia (L-CAP), an Immunological Phenotype Associated with Higher Risk of Mortality
por: Bermejo-Martin, Jesus F., et al.
Publicado: (2017)

Simultaneous Depression of Immunological Synapse and Endothelial Injury is Associated with Organ Dysfunction in Community-Acquired Pneumonia
por: Menéndez, Rosario, et al.
Publicado: (2019)

Effect of Corticosteroids on C-Reactive Protein in Patients with Severe Community-Acquired Pneumonia and High Inflammatory Response: The Effect of Lymphopenia
por: Torres, Antoni, et al.
Publicado: (2019)

Research in community-acquired pneumonia: the next steps
por: Torres, Antoni, et al.
Publicado: (2017)

Biomarkers in Community-Acquired Pneumonia (Cardiac and Non-Cardiac)
por: Méndez, Raúl, et al.
Publicado: (2020)

Severe community-acquired pneumonia
por: Niederman, Michael S., et al.
Publicado: (2022)

Predictors of Severe Sepsis among Patients Hospitalized for Community-Acquired Pneumonia
por: Montull, Beatriz, et al.
Publicado: (2016)

Lymphocytopenia as a Predictor of Mortality in Patients with ICU-Acquired Pneumonia
por: Ceccato, Adrian, et al.
Publicado: (2019)

Impact on in-hospital mortality of ceftaroline versus standard of care in community-acquired pneumonia: a propensity-matched analysis
por: Cilloniz, Catia, et al.
Publicado: (2021)

PES Pathogens in Severe Community-Acquired Pneumonia
por: Cillóniz, Catia, et al.
Publicado: (2019)

Cytokine Activation Patterns and Biomarkers Are Influenced by Microorganisms in Community-Acquired Pneumonia
por: Menéndez, Rosario, et al.
Publicado: (2012)

Lymphopenia Is Associated With Poor Outcomes of Patients With Community-Acquired Pneumonia and Sepsis
por: Cilloniz, Catia, et al.
Publicado: (2021)

Community-acquired pneumonia
por: Prina, Elena, et al.
Publicado: (2015)

Non-lymphopenic pneumocystis pneumonia in low-dose methotrexate therapy: An exception to every rule
por: Lourenço, Jorge, et al.
Publicado: (2020)

Predicting treatment failure in patients with community acquired pneumonia: a case-control study
por: Martin-Loeches, Ignacio, et al.
Publicado: (2014)

Mounting evidence of impaired viral control in severe COVID-19
por: Bermejo-Martin, Jesus F, et al.
Publicado: (2021)

Pneumococcal Serotypes Associated with Community-Acquired Pneumonia Hospitalizations in Adults in Spain, 2016–2020: The CAPA Study
por: Menéndez, Rosario, et al.
Publicado: (2023)

IgA level in plasma as a differential factor for influenza infection in severe viral pneumonia
por: Almansa, Raquel, et al.
Publicado: (2014)

Community-Acquired Pneumonia
por: Sialer, Salvador, et al.
Publicado: (2014)

Defining Community-Acquired Pneumonia as a Public Health Threat: Arguments in Favor from Spanish Investigators
por: Cillóniz, Catia, et al.
Publicado: (2020)

RESPONSE OF LYMPHOPENIC PLATELETPHERESIS DONORS TO COVID-19 VACCINATION
por: Bazin, Renee, et al.
Publicado: (2023)

Inflammatory response in mixed viral-bacterial community-acquired pneumonia
por: Bello, Salvador, et al.
Publicado: (2014)

What’s new in severe community-acquired pneumonia? Corticosteroids as adjunctive treatment to antibiotics
por: Torres, Antoni, et al.
Publicado: (2015)

Treatment with macrolides and glucocorticosteroids in severe community-acquired pneumonia: A post-hoc exploratory analysis of a randomized controlled trial
por: Ceccato, Adrian, et al.
Publicado: (2017)

Serum levels of immunoglobulins and severity of community-acquired pneumonia
por: de la Torre, Mari C, et al.
Publicado: (2016)

ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia
por: Martin-Loeches, Ignacio, et al.
Publicado: (2023)

Bacterial co-infection with H1N1 infection in patients admitted with community acquired pneumonia
por: Cillóniz, Catia, et al.
Publicado: (2012)

Inflammasome activation and pyroptosis in lymphopenic liver patients with COVID-19
por: Kroemer, Alexander, et al.
Publicado: (2020)

Challenges in severe community-acquired pneumonia: a point-of-view review
por: Torres, Antoni, et al.
Publicado: (2019)

Risk and Prognostic Factors in Very Old Patients with Sepsis Secondary to Community-Acquired Pneumonia
por: Cillóniz, Catia, et al.
Publicado: (2019)

Severe community-acquired pneumonia
por: Morgan, AJ, et al.
Publicado: (2016)

Severe Community-Acquired Pneumonia
por: Khatib, Khalid, et al.
Publicado: (2019)

Severe Community-Acquired Pneumonia
por: Sligl, Wendy I., et al.
Publicado: (2013)

Host-targeted approaches to sepsis due to community-acquired pneumonia
por: Cilloniz, Catia, et al.
Publicado: (2022)

Challenges in understanding host genetics and severity of community-acquired pneumonia
por: Solé-Violán, Jordi, et al.
Publicado: (2021)

The Evolution and Distribution of Pneumococcal Serotypes in Adults Hospitalized With Community-Acquired Pneumonia in Spain Using a Serotype-Specific Urinary Antigen Detection Test: The CAPA Study, 2011–2018
por: Torres, Antoni, et al.
Publicado: (2021)

Corticosteroids as Adjunctive Therapy in Severe Community-Acquired Pneumonia
por: Cillóniz, C., et al.
Publicado: (2016)

A distinct influenza infection signature in the blood transcriptome of patients with severe community-acquired pneumonia
por: Parnell, Grant P, et al.
Publicado: (2012)

Multidrug Resistant Gram-Negative Bacteria in Community-Acquired Pneumonia
por: Cillóniz, Catia, et al.
Publicado: (2019)

Adjuvant therapies in critical care: steroids in community-acquired pneumonia
por: Torres, Antoni, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_s041deos4gvq60q2cuottud2i1